Patient Engagement Experience – Add a Pinch of Perception, Sustainability, and Analytics to Your Existing Database and See the Difference

The world today is moving towards a proactive than reactive approach. Most pharmaceutical and medical device companies depend on expensive clinical and drug user databases that charge them hefty subscription fees for feeds that are mostly available in the public domain.

Key Takeaways:

  • The convergence of patient experience, perception, and decision-making process should be merged with the offerings and solutions.
  • With data convergence set to play a major role in PEP, wearables, learning, and development, marketing, app-based data, and salesforce data (from drug/product companies) will become integrated.
  • Dependency on fixed metrics on subscription-based databases will also lead to major failures of strategy.

To know more...

Related Topics

SGA - M&E - Whitepaper - FAST Accelerator


FAST Accelerator in Today’s Hybrid Monetization Era

Unified PaaS is set to become the new norm to help improve margins and reduce the total cost of ownership (TCO). FAST (free ad-supported streaming TV)...

SG Analytics Whitepaper B2B Payments


B2B Payments: Is Cash Still a King or Now is the Time for...

The global B2B payments industry seems to be highly fragmented, with a lack of clear vendors holding the lion’s share in the market. The advent of new...

SG Analytics Whitepaper Reusable Data Products and Patterns Can Unlock New Opportunities


Reusable Data Products and Patterns Can Unlock New...

Despite recognizing the power of data, and the likelihood of the emergence of smart workflows and seamless communications between humans and machines in the...

We bring comprehensive data driven insights to everyone, everywhere